ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Targeting RNA-binding protein HuR to inhibit the progression of renal tubular fibrosis
dc.contributor.author | Huang, Zhimin | |
dc.contributor.author | Liu, Simeng | |
dc.contributor.author | Tang, Anna | |
dc.contributor.author | Wu, Xiaoqing | |
dc.contributor.author | Aube, Jeffrey | |
dc.contributor.author | Xu | |
dc.contributor.author | Huang, Yufeng | |
dc.date.accessioned | 2023-07-10T21:21:14Z | |
dc.date.available | 2023-07-10T21:21:14Z | |
dc.date.issued | 2023-06-30 | |
dc.identifier.citation | Huang, Z., Liu, S., Tang, A., Wu, X., Aube, J., Xu, L., & Huang, Y. (2023). Targeting RNA-binding protein HuR to inhibit the progression of renal tubular fibrosis. Journal of translational medicine, 21(1), 428. https://doi.org/10.1186/s12967-023-04298-x | en_US |
dc.identifier.uri | https://hdl.handle.net/1808/34576 | |
dc.description.abstract | Background Upregulation of an RNA-binding protein HuR has been implicated in glomerular diseases. Herein, we evaluated whether it is involved in renal tubular fibrosis.Methods HuR was firstly examined in human kidney biopsy tissue with tubular disease. Second, its expression and the effect of HuR inhibition with KH3 on tubular injury were further assessed in a mouse model induced by a unilateral renal ischemia/reperfusion (IR). KH3 (50 mg kg−1) was given daily via intraperitoneal injection from day 3 to 14 after IR. Last, one of HuR-targeted pathways was examined in cultured proximal tubular cells.Results HuR significantly increases at the site of tubular injury both in progressive CKD in patients and in IR-injured kidneys in mice, accompanied by upregulation of HuR targets that are involved in inflammation, profibrotic cytokines, oxidative stress, proliferation, apoptosis, tubular EMT process, matrix remodeling and fibrosis in renal tubulointerstitial fibrosis. KH3 treatment reduces the IR-induced tubular injury and fibrosis, accompanied by the remarkable amelioration in those involved pathways. A panel of mRNA array further revealed that 519 molecules in mouse kidney following IR injury changed their expression and 71.3% of them that are involved in 50 profibrotic pathways, were ameliorated when treated with KH3. In vitro, TGFβ1 induced tubular HuR cytoplasmic translocation and subsequent tubular EMT, which were abrogated by KH3 administration in cultured HK-2 cells.Conclusions These results suggest that excessive upregulation of HuR contributes to renal tubulointerstitial fibrosis by dysregulating genes involved in multiple profibrotic pathways and activating the TGFß1/HuR feedback circuit in tubular cells. Inhibition of HuR may have therapeutic potential for renal tubular fibrosis. | en_US |
dc.publisher | BMC | en_US |
dc.rights | © The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_US |
dc.subject | RNA-binding protein | en_US |
dc.subject | HuR inhibitor | en_US |
dc.subject | Ischemia–reperfusion | en_US |
dc.subject | Renal fibrosis | en_US |
dc.subject | Chronic kidney disease | en_US |
dc.title | Targeting RNA-binding protein HuR to inhibit the progression of renal tubular fibrosis | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Wu, Xiaoqing | |
kusw.kuauthor | Xu, Liang | |
kusw.kudepartment | Molecular Biosciences | en_US |
dc.identifier.doi | 10.1186/s12967-023-04298-x | en_US |
kusw.oaversion | Scholarly/refereed, publisher version | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC10311833 | en_US |
dc.rights.accessrights | openAccess | en_US |